Showing posts with label shunt. Show all posts
Showing posts with label shunt. Show all posts

05 November 2007

A Passionate Plea Against Patents

One of the winners of the the 2007 essay contest on "Equitable access: research challenges for health in developing countries" is the following passionate diatribe against the murderous inequity of patents:

The usual, if untenable, reason for granting patent monopolies is that excess revenue is spent on research for new drugs and that this stimulates further research and leads to more innovations. On the contrary, there is hardly any pharmaceutical company that spends more than 15% of its annual revenue on research. The rest goes to other things: advertising, marketing, lobbying, etc. Their research on diseases found in developing countries has always been insufficient. New drugs for the treatment of tropical diseases are rare and far between, and are often not the result of pharmaceutical industry research. Research is expensive and requires lots of money, no doubt. It takes resources to generate innovation. However, maintaining pharmaceutical patents is even more expensive. Like Belding Scribner’s shunt, innovation must address needs and reach the people who have those needs; otherwise it is not innovation.

What we need is a paradigm shift, a new way of organizing, promoting and financing research and innovation, one that would ensure an intercontinental balance of interests and research priorities.

(Via Open Access News.)